MPVLR Glasgow预后评分与急性冠脉综合征患者PCI一年内预后的关系

doi:10.3969/j.issn.1006-6233.2023.04.026

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1251 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the correlation of the mean platelet volume to lymphocyte ratio (MPVLR), Glasgow prognosis score (Glasgow) and the prognosis of patients with acute coronary syndrome after percutaneous coronary intervention (PCI). Methods: A total of 98 patients with acute coronary syndrome treated in our hospital from January 2019 to July 2021 were selected, according to whether major adverse cardiovascular events (MACE) such as cardiac or all-cause death and acute heart failure occurred one year after operation, they were divided into poor prognosis group and good prognosis group, with 30 cases and 68 cases respectively. The differences of clinical data such as GRACE score, Glasgow score and MPVLR of patients with poor prognosis and those with good prognosis were observed and compared. Results: The admission GRACE score of patients with poor prognosis was (145.50 ± 19.29), which was significantly higher than that of patients with good prognosis (P<0.05). The proportion of Glasgow score 1-2 in patients with poor prognosis was 80.00%, which was significantly higher than that in patients with good prognosis (P<0.05). The peak values of MPVLR and cardiac troponin T (cTnT) in patients with poor prognosis were (6.90 ± 1.01) and (6.69 ± 1.32) ng / ml, respectively, which were significantly higher than those in patients with good prognosis (P<0.05). The left ventricular ejection fraction (LVEF) of patients with poor prognosis was (46.60 ± 7.82)%, which was significantly lower than that of patients with good prognosis (P<0.05); Logistic regression analysis showed that Glasgow score, MPVLR and LVEF were the influencing factors of poor prognosis after PCI in patients with acute coronary syndrome (P<0.05). Conclusion: MPVLR and Glasgow scores at admission are related to poor prognosis of patients with acute coronary syndrome after PCI, which is worthy of further study.

Key words： Acute coronary syndrome Mean platelet volume to lymphocyte ratio Glasgow prognostic score Percutaneous coronary intervention Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Tongchang
	LI Haishan

Cite this article:

ZHANG Tongchang,LI Haishan. Association of MPVLR Glasgow Prognostic Score and Prognosis within One Year of PCI in Patients with Acute Coronary Syndrome[J]. HeBei Med, 2023, 29(4): 658-663.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2023.04.026 OR http://www.hbyxzzs.cn/EN/Y2023/V29/I4/658

[1] Piroli F,Leone A M,Calcagno S.The role of chronic obstructive pulmonary disease in acute coronary syndrome patients:a critical risk factor for lipid plaque burden[J].Minerva Cardioangiologica,2021,69(6):735-737.
[2] Hayajneh A A,Rababa M,Al-Rawashedeh S.Time to seek care and hospital length of stay among older adults with acute coronary syndrome during the COVID-19 pandemic[J].Clinical Nursing Research,2022,31(3):364-375.
[3] Elbehairy M M,Abdelnasser H Y,Hanafi R S,et al.An intronic DHCR7 genetic polymorphism associates with vitamin D serum level and incidence of acute coronary syndrome[J].Steroids,2021,169(5):108825.
[4] Toth P P,Schwartz G G,Nicholls S J,et al.Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score:exploratory analysis of the BETonMACE trial[J].European Heart Journal,2021,22(11):3321.
[5] Kalantar-Zadeh K,Schwartz G G,Nicholls S J,et al.Effect of apabetalone on cardiovascular events in diabetes,CKD,and recent acute coronary syndrome:results from the BETonMACE randomized controlled trial[J].Clinical Journal of the American Society of Nephrology,2021,16(5):705-716.
[6] Zhang W,Kong Y,Wang L,et al.Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention:a cohort study[J].Medicine,2020,99(33):20805.
[7] 王康鸣,吉家钗,王琦,等.高Glasgow预后评分与急性冠脉综合征患者的全因死亡率和心血管死亡率独立相关[J].内科急危重症杂志,2022,28(2):133-136.
[8] Koseoglu C,Kurmus O.Association between mean platelet volume-to-lymphocyte ratio and the presence of apical mural thrombus in post-myocardial infarction patients[J].International Journal of Cardiovascular Sciences,2020,33(33):422.
[9] Angkananard T,Inthanoo T,Sricholwattana S,et al.The predictive role of neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume-to-lymphocyte ratio (MPVLR) for cardiovascular events in adult patients with acute heart failure.[J].Hindawi Limited,2021,18(8):6889733.
[10] 中国医师协会急诊医师分会,中华医学会心血管病学分会,中华医学会检验医学分会.急性冠脉综合征急诊快速诊疗指南[J].中华危重症医学杂志(电子版),2016,9(2):73-80.
[11] Zhu K,Zheng Y S,Fang Y.Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention:a protocol for systematic review and meta-analysis[J].Medicine,2020,99(44):22918.
[12] 袁健瑛,程毅松,贾禹,等.基于炎症的格拉斯哥预后评分对急性ST段抬高型心肌梗死患者预后的预测价值分析[J].中国胸心血管外科临床杂志,2020,27(1):14-19.
[13] 邹洋,王慎旭.急性ST段抬高型心肌梗死患者PCI术后不同预后患者凝血功能的研究[J].川北医学院学报,2020,35(2):255-258.
[14] Chen Z,Li N,Wang J,et al.Association between mean platelet volume and major adverse cardiac events in percutaneous coronary interventions:a systematic review and meta-analysis[J].Coronary Artery Disease,2020,31(8):722-732.